Skip to content
City AM
Main navigation
Download free app
  • News
    • News
      • Latest Business News
      • Economics
      • Politics
      • Tech
      • Banking
      • FTSE 100 Live
      • Retail
      • Insurance
      • Legal
      • Property
      • Transport
      • Markets
    • From our partners
      • AON
      • Bayes Business School
      • City of London BIDs
      • Central London Alliance CIC
      • Destination City
      • Halkin
      • Olympia
      • Inside Saudi
      • Tottenham Hotspur Stadium
      • Santander X
      • YEAR SIX Dividend
    • Featured

      Heatwave fans demand for aircon stocks

      Submit a story

      Tell us your story.

      Submit
  • Opinion
  • Sport
    • Latest Sports News
      • Sport
      • Sport Business
      • The Punter
    • From our partners
      • The Morning Briefing: SBS x City AM
      • Aramco Team Series
      • LIV Golf
    • Featured

      Novak Djokovic joins investment firm with stake in Mexico’s Azteca Stadium

      Previews: The Championships - Wimbledon 2026

      Submit a story

      Tell us your story.

      Submit
  • Life&Style
    • Life&Style
      • Life&Style
      • Toast the City Awards
      • The Magazine
      • Travel
      • Culture
      • Motoring
      • Wellness
      • City AM Puzzles
      • The RED BULLETiN
      • Do it with Shared Ownership
      • Media Speak Hub
    • Featured

      House of the Dragon’s Abubakar Salim dreams of Kenyan kebabs for his last supper

      Submit a story

      Tell us your story.

      Submit
  • Investec
  • Events
  • Newsletters
  • Latest Paper

By: Kat Denham

All 247164 Articles
  • US pharma giants to merge under $145m deal to tackle opioid overdose epidemic

    November 14, 2022

    Indivior, a US pharmaceutical heavyweight, has bought addiction and overdose treatment competitor Opiant Pharmaceuticals for $145m (£123m) The FTSE 250 pharma firm is coughing up some $20.00 per share in cash upfront, Indivior said in a statement today. Plus, a further $8.00 a piece should revenue milestones be achieved over the next seven years. Both [...]

  • Locals slam Sky Studios new Elstree movie hub

    November 14, 2022

    Locals have slammed Sky Studios’ plans to expand its Elstree film and TV hub, which could create 2,000 new jobs for the local area according to the media giant. Dubbed Sky Studios Elstree North, the plans – which are subject to planning permission – would take the total number of soundstages onsite to 23, and [...]

  • Madame Tussauds owner names Scott M. O’Neil as new CEO

    November 14, 2022

    Legoland theme park owner Merlin Entertainment has announced its new chief executive officer as Scott M. O’Neil. The Alton Towers and Madame Tussauds owner said on Monday that O’Neil will step into the shoes of outgoing boss Nick Varney, who has served a 23-year stint. O’Neil’s CV boasts previous roles including a stint as CEO [...]

  • Crypto firms look to soothe jitters as Binance announces recovery fund

    November 14, 2022

    Crypto exchanges have looked to cool investors' fears of contagion today as the industry is rocked by the shockwaves of FTX’s collapse last week.

  • Misty Monday: Dozens of flights cancelled at London airports as fog engulfs capital

    November 14, 2022

    Dozens of flights have been cancelled over the past few hours at London airports as the fog that engulfed the capital since yesterday continues to present a risk to operations.  British Airways – which was forced to cancel 15 domestic and short-haul flights to Heathrow – said it was doing everything it could to get [...]

  • Roche shares dip as hope for long-awaited Alzheimer’s drug quickly fades

    November 14, 2022

    Shares in Swiss pharmaceutical giant dipped today after disappointing results from its late-stage Alzheimer’s drug. The drug, known as Gantenerumab, was seen as a high-risk but high-reward drug, according to Sebastian Skeet, senior healthcare analyst at investment research firm Third Bridge. However, the treatment failed to slow the progression of dementia across two ongoing trials. [...]

  • Primark website crashes on first day of click and collect trial

    November 14, 2022

    Primark’s first foray into online shopping hit a hurdle on Monday morning as the high street name’s website crashed. The budget apparel seller has launched a trial in 25 stores in north-west England and north Wales, for children’s clothes to begin with. “We’re working hard to address this to ensure that everyone can access and [...]

  • Badenoch to push for ‘muscular liberalism and free trade’ in US trip

    November 14, 2022

    The UK and US must show the world that “muscular liberalism and free trade are a force for good”, trade secretary Kemi Badenoch has said before her trip to Washington. The Department for International Trade (DIT) said Badenoch, who is leaving today, would “promote UK-US trade” during her trip while speaking out against protectionism. Badenoch [...]

  • Children need more than piggy banks to aspire to – we must step up and foster financial literacy

    November 14, 2022

    June Felix of IG Group says we have a collective responsibility to make a positive impact on financial literacy for children.

  • Workers at Jaffa Cake bars factory threaten ‘permanent strike’ over pay

    November 14, 2022

    MORE than 750 workers at the Jaffa Cake bars factory have threatened to stage a permanent walkout over pay until bosses agree to get back to the negotiation table. Staff at the Aintree plant – who also make Jacobs Cream Crackers and Twiglets – have been taking limited industrial action since September over cost of [...]

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 2,549
  • Page 2,550
  • Page 2,551
  • Page 2,552
  • Page 2,553
  • …
  • Page 24,717
  • Next

Trending Articles

  • House of the Dragon’s Abubakar Salim dreams of Kenyan kebabs for his last supper

  • Heatwave fans demand for aircon stocks

  • Could The Billingsgate Roman Bathhouse win a Toast award?

  • Lessons in comms from my children’s primary school

  • Novak Djokovic joins investment firm with stake in Mexico’s Azteca Stadium

Subscribe

Subscribe to the City AM newsletter to have our top stories delivered directly to your inbox.

Subscribe
  • Got a story?
  • About City AM
  • Careers
  • Terms & Conditions
  • Privacy Policy
  • Cookie Policy
  • News
  • Markets & Economics
  • Politics
  • Opinion
  • Life&Style
  • Personal Finance
  • City AM Events
  • City Winners
  • The Punter
  • Casino
  • City AM Puzzles

Follow us for breaking news and latest updates

  • Facebook
  • X
  • Instagram
  • LinkedIn
  • Newsletters
  • Advertising
  • About
  • Licensing
Copyright 2026 City AM Limited